The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $138.33

Today's change-3.59 -2.53%
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $138.33

Today's change-3.59 -2.53%
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.

Edwards Lifesciences Corp crosses below 50-day moving average

Edwards Lifesciences Corp closed sharply lower Friday, dropping (U.S.)$3.59 or 2.53% to (U.S.)$138.33 and crossing below its 50-day moving average. Shares have lost 1.15% over the last five days, but have gained 8.60% over the last year to date. This security has outperformed the S&P 500 by 59.60% during the last year.

Key company metrics

  • Open(U.S.) $144.37
  • Previous close(U.S.) $141.92
  • High(U.S.) $144.43
  • Low(U.S.) $136.32
  • Bid / Ask-- / --
  • YTD % change+8.60%
  • Volume2,303,213
  • Average volume (10-day)896,940
  • Average volume (1-month)907,943
  • Average volume (3-month)1,008,686
  • 52-week range(U.S.) $78.12 to (U.S.) $150.41
  • Beta0.60
  • Trailing P/E18.40×
  • P/E 1 year forward32.84×
  • Forward PEG2.42×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $7.52
Updated April 24 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+36.57%

Based on its net profit margin of 36.57%, Edwards Lifesciences Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue618607575522
Total other revenue--------
Total revenue618607575522
Gross profit458439424377
Total cost of revenue160168151146
Total operating expense485487-238445
Selling / general / administrative223222216197
Research & development84888986
Depreciation / amortization--------
Interest expense (income), net operating4445
Unusual expense (income)114-6979
Other operating expenses, total0100
Operating income13312181377
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax13312181377
Income after tax1099554760
Income tax, total242626617
Net income1099554760
Total adjustments to net income--------
Net income before extra. items1099554760
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1099554760
Inc. avail. to common incl. extra. items1099554760
Diluted net income1099554760
Dilution adjustment--00--
Diluted weighted average shares110108107109
Diluted EPS excluding extraordinary itemsvalue per share1.000.875.090.56
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share1.080.900.730.62